Prime Medicine, Inc. Quarterly Entity Common Stock, Shares Outstanding from Q3 2022 to Q2 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Prime Medicine, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q3 2022 to Q2 2024.
  • Prime Medicine, Inc. Entity Common Stock, Shares Outstanding for the quarter ending August 1, 2024 was 120M shares, a 23.4% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 120M +22.7M +23.4% Aug 1, 2024 10-Q 2024-08-08
Q1 2024 120M +22.8M +23.4% May 1, 2024 10-Q 2024-05-10
Q3 2023 97.3M +116K +0.12% Oct 31, 2023 10-Q 2023-11-03
Q2 2023 97.3M Jul 31, 2023 10-Q 2023-08-07
Q1 2023 97.2M Mar 7, 2023 10-K 2023-03-09
Q3 2022 97.2M Nov 8, 2022 10-Q 2022-11-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.